GSK plc vs HP Inc — how do they compare? GSK plc trades at $52.74 (market cap $101.34B), while HP Inc trades at $23.85 (market cap $21.72B). The key difference: GSK plc is far larger — about 4.7× HP Inc's market cap, and HP Inc pays the higher dividend (5.05%). Which is the better fit depends on your goals.
| GSK | HPQ | |
|---|---|---|
Market Cap | $101.34B | $21.72B |
Sector | Health | Technology |
52-Week High | $61.18 | $29.35 |
52-Week Low | $36.20 | $18.20 |
Enterprise Value | $121.95B | $28.88B |
Dividend Yield | 3.49% | 5.05% |
Signals from Pluang's Aura AI — not financial advice
GSK trades at $52.64, up 2.7% on the day, with a bearish technical signal despite recent earnings beats. The company reported Q1 2026 EPS of $1.24, beating estimates of $1.16, and maintains strong profitability with a 17.78% net income margin. Positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline strength, while a pending acquisition of Nuvalent, Inc. signals strategic expansion.
GSK offers value with a P/E of 13.71 and stable cash flows, but faces risks from clinical setbacks, as seen in the terminated Alector partnership. Analyst sentiment is mixed with 31% buy ratings, reflecting cautious optimism amid competitive and regulatory pressures. The stock's outlook hinges on execution of growth initiatives and pipeline developments.
HPQ trades at $23.71, down 3.74% over 24 hours, with a bullish technical signal from moving averages and ADX indicators. Fundamentally, the stock shows value with a P/E of 8.8 and P/S of 0.39, supported by three consecutive quarterly EPS beats. Recent developments include a strategic partnership with OpenAI and a dividend yield near 5%, while cash flow trends improved to a net $460 million in 2025.
The outlook balances undervaluation and dividend appeal against PC market headwinds and negative equity. Risks include industry shipment declines and competitive pressure, but analyst consensus leans hold with a $22 price target, suggesting cautious optimism for AI-driven growth opportunities.
Trailing returns across standard periods
Latest headlines on both assets
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →HP Incorporated is a leading provider of computers, printers, and printer supplies. The company's mains segments are personal systems and printing. Its personal systems segment contains notebooks, desktops, and workstations. Its printing segment contains supplies, consumer hardware, and commercial hardware. In 2015, Hewlett-Packard was separated into HP Incorporated and Hewlett Packard Enterprise and the Palo Alto, California-based HP Incorporated sells on a global scale.
Read more on HPQ →